Luo Chuan-Hong, Ma Le-le, Liu Hui-Min, Liao Wei, Xu Run-Chun, Ci Zhi-Min, Lin Jun-Zhi, Han Li, Zhang Ding-Kun
School of Pharmacy, State Key Laboratory of Characteristic Chinese Drug Resources in Southwest China, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Central Laboratory, Teaching Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Front Pharmacol. 2020 Sep 11;11:556885. doi: 10.3389/fphar.2020.556885. eCollection 2020.
Novel coronavirus (COVID-19) pneumonia has become a major threat to worldwide public health, having rapidly spread to more than 180 countries and infecting over 1.6 billion people. Fever, cough, and fatigue are the most common initial symptoms of COVID-19, while some patients experience diarrhea rather than fever in the early stage. Many herbal medicine and Chinese patent medicine can significantly improve these symptoms, cure the patients experiencing a mild 22form of the illness, reduce the rate of transition from mild to severe disease, and reduce mortality. Therefore, this paper summarizes the physiopathological mechanisms of fever, cough, fatigue and diarrhea, and introduces Chinese herbal medicines (Ephedrae Herba, Gypsum Fibrosum, Glycyrrhizae Radix et Rhizoma, Asteris Radix et Rhizoma, Ginseng Radix et Rhizoma, Codonopsis Radix, Atractylodis Rhizoma, ) and Chinese patent medicines (Shuang-huang-lian, Ma-xing-gan-shi-tang, ) with their corresponding therapeutic effects. Emphasis was placed on their material basis, mechanism of action, and clinical research. Most of these medicines possess the pharmacological activities of anti-inflammatory, antioxidant, antiviral, and immunity-enhancement, and may be promising medicines for the treatment or adjuvant treatment of COVID-19 patients.
新型冠状病毒(COVID-19)肺炎已成为全球公共卫生的重大威胁,迅速传播至180多个国家,感染人数超过16亿。发热、咳嗽和乏力是COVID-19最常见的初始症状,而一些患者在疾病早期会出现腹泻而非发热症状。许多草药和中成药能够显著改善这些症状,治愈轻症患者,降低轻症转重症的比例,并降低死亡率。因此,本文总结了发热、咳嗽、乏力和腹泻的生理病理机制,并介绍了具有相应治疗作用的草药(麻黄、石膏、甘草、紫菀、人参、党参、白术)和中成药(双黄连、麻杏甘石汤)。重点阐述了它们的物质基础、作用机制及临床研究。这些药物大多具有抗炎、抗氧化、抗病毒和增强免疫力的药理活性,可能是治疗或辅助治疗COVID-19患者的有前景的药物。